Trial Profile

Clinical Trials Insight: 700035680

Status: Not yet recruiting

Phase of Trial: Phase III

Latest Information Update: 10 Jun 2009

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Adenosine triphosphate (Primary)
Indications Paroxysmal supraventricular tachycardia
Focus Registrational; Therapeutic Use
Sponsors Cordex Pharma

Most Recent Events

02 Jun 2009 Status changed from planning to not yet recruiting, according to a Cordex Pharma media release.
18 Feb 2009 Amended phase III protocol submitted to FDA, according to a media release from Cordex Pharma.
20 Nov 2008 According to a Duska Therapeutics media release, this trial is expected to commence in quarter 1 of 2009.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com